PALYNZIQ
PALYNZIQ
Approved
DIN Number
02526263
Drug Class
Human
Market Date
Aug 26, 2022
Company
HC
Biomarin International Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526263
AIG Number0163521001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB19 PEGVALIASE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PEGVALIASEActive
Strength: 20 MG / ML
Monograph: PEGVALIASE